(PRESCRIPTION TRANQUILIZING DRUGS) Yt. G?? : Ad1 HEARINGS STANFOR BEFORE A JUL UNIVERSITY 1958 SUBCOMMITTEE OF THE COMMITTEE ON COMMITTEE ON GOVERNMENT OPERATIONS WILLIAM L. DAWSON, Illinois, Chairman CHET HOLIFIELD, California CLARE E. HOFFMAN, Michigan JOHN W. McCORMACK, Massachusetts R. WALTER RIEHLMAN, New York JACK BROOKS, Texas CECIL M. HARDEN, Indiana L. H. FOUNTAIN, North Carolina CHARLES B. BROWNSON, Indiana PORTER HARDY, JR., Virginia GEORGE MEADER, Michigan JOHN A. BLATNIK, Minnesota CLARENCE J. BROWN, Ohio ROBERT E. JONES, Alabama GLENARD P. LIPSCOMB, California EDWARD A. GARMATZ, Maryland VICTOR A. KNOX, Michigan JOHN E. MOSS, California WILLIAM E. MINSHALL, Ohio JOE M. KILGORE, Texas EDWIN H. MAY, Jr., Connecticut DANTE B. FASCELL, Florida ROBERT H. MICHEL, Illinois MARTHA W. GRIFFITHS, Michigan FLORENCE P. DWYER, New Jersey HENRY S. REUSS, Wisconsin OVERTON BROOKS, Louisiana ELIZABETH KEE, West Virginia KATHRYN E. GRANAHAN, Pennsylvania CHRISTINE RAY DAVIS, Staff Director ORVILLE S. POLAND, General Counsel J. P. CARLSON, Minority Counsel LEGAL AND MONETARY AFFAIRS SUBCOMMITTEE JOHN A. BLATNIK, Minnesota, Chairman JOE M. KILGORE, Texas GEORGE MEADER, Michigan WILLIAM E. MINSHALL, Ohio MEMBERS EX OFFICIO CLARE E. HOFFMAN, Michigan JEROME S. PLAPINGER, Counsel JEROME SONOSRY, Associate Counsel JOHN L. ANDERSON, Investigator CONTENTS Statement of Anderson, Sigurd, Commissioner, Federal Trade Commission; accom panied by Earl Kintner, general counsel; John T. Laughlin, assist- 159 Ayd, Dr. Frank J., Jr., practicing psychiatrist and medical researcher, Baltimore, Md. 47, 90 Bartemeier, Dr. Leo, chairman, council on mental health, American Medical Association, past president of the Psychiatric Association, and director of the Seton Institute, Baltimore, Md.; accompanied by Dr. Lauren A. Woods, associate professor of pharmacology, University of Michigan Medical School, Ann Arbor, Mich.; and Dr. Malcolm Phelps, president, academy of general practice, and member of house of delegates of the American Medical Association.- 64 Dowling, Dr. Harry F., head of the Department of Medicine, College of Medicine, University of Illinois. 129 Holland, Dr. Albert H., Jr., Medical Director of the Food and Drug Administration.. 145 Kline, Nathar S., M. D., director of research, Rockland State Hospital, New York Department of Mental Hygiene. 3 Steele, Dr. J. Murray, chairman, committee on public health, New York Academy of Medicine.. 78 Stevenson, Dr. Ian, professor and chairman, Department of Neurology and Psychiatry, University of Virginia, Charlottesville, Va. 115 Letters, statements, etc., submitted for the record byAnderson, Sigurd, Commissioner, Federal Trade Commission: Court of appeals decision re advertising material. 161 Excerpt from the Federal Trade Commission Act. 160 Federal Trade Commission order to cease and desist-Koch Laboratories, Inc., et al. (206 Fed. 311 (1953))- 160 Ayd, Dr. Frank J., Jr., practicing psychiatrist and medical researcher, Baltimore, Md. Claim of tranquilizer. 111 Comparison between 4 drugs, based on an article published in December 1956, footnote.. 110 Excerpt from Associated Press release re drugs. 102 Excerpt from "out of context quotation” involving a drug being clinically investigated by Dr. Frank J. Ayd, Jr. 90 Excerpt from report on 92 patients, April 26, 1956_ 92 Excerpt from statement. 102 Blatnik, Hon. John A., a Representative in Congress from the State of Minnesota, and chairman, Legal and Monetary Affairs Subcom- New England Journal of Medicine, entitled, “Editorial Respon- 89 Excerpt from the New York Academy of Medicine report on advertising of tranquilizing drugs-- 77 Dowling, Dr. Harry F., head of the Department of Medicine, College of Medicine, University of Illinois: Biographical sketch. 130 Kline, Nathan S., M. D., director of research, Rockland State Hospital, New York Department of Mental Hygiene: Excerpt from an article re grants-in-aid. 2 Statement 37 15 |